Výsledky vyhledávání - "Marline G Harmsen"

Evaluation of a patient decision aid for BRCA1/2 pathogenic variant carriers choosing an ovarian cancer prevention strategy

Autor: Ronald P. Zweemer, Jurgen M.J. Piek, Joanna IntHout, Majke H.D. van Bommel, M. Caroline Vos, Rosella P.M.G. Hermens, Luc R.C.W. van Lonkhuijzen, Marline G. Harmsen, Mirjam J.A. Apperloo, Miranda P. Steenbeek, Marc van Beurden, José H.M. Keurentjes, Katja N. Gaarenstroom, Nicoline Hoogerbrugge, Monique M.A. Brood-van Zanten, Sjors F.P.J. Coppus, Charlotte G.J. Penders, Helena C. van Doorn, Joanne A. de Hullu

Publikováno v: Gynecologic Oncology, 163(2), 371-377. ACADEMIC PRESS INC ELSEVIER SCIENCE
Gynecologic oncology, 163(2), 371-377. Academic Press Inc.
Steenbeek, M P, van Bommel, M H D, Harmsen, M G, Hoogerbrugge, N, van Doorn, H C, Keurentjes, J H M, van Beurden, M, Zweemer, R P, Gaarenstroom, K N, Penders, C G J, Brood-van Zanten, M M A, Vos, M C, Piek, J M, van Lonkhuijzen, L R C W, Apperloo, M J A, Coppus, S F P J, IntHout, J, de Hullu, J A & Hermens, R P M G 2021, ' Evaluation of a patient decision aid for BRCA1/2 pathogenic variant carriers choosing an ovarian cancer prevention strategy ', Gynecologic Oncology, vol. 163, no. 2, pp. 371-377 . https://doi.org/10.1016/j.ygyno.2021.08.019
Gynecologic Oncology, 163, 2, pp. 371-377
Gynecologic Oncology, 163(2), 371-377. Academic Press
Gynecologic Oncology, 163(2), 371-377. Elsevier Science
Gynecologic Oncology, 163(2), 371-377. Academic Press Inc.
Gynecologic Oncology, 163, 371-377

Objective. Risk-reducing surgery is advised to BRCA1/2 pathogenic variant (PV) carriers around the age of 40 years to reduce ovarian cancer risk. In the TUBA-study, a multicenter preference study (NCT02321228), BRCA1/2-PV carriers are offered a choic

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c22acf9acf2962a21cb516c5415e9965
http://www.scopus.com/inward/record.url?scp=85113744140&partnerID=8YFLogxK

Zobrazit plný text záznamu

Contraceptives and cancer risks in BRCA1/2 pathogenic variant carriers: a systematic review and meta-analysis

Autor: Majke H D van Bommel, Joanna IntHout, Guus Veldmate, C Marleen Kets, Joanne A de Hullu, Anne M van Altena, Marline G Harmsen

Publikováno v: Human Reproduction Update, 29, 197-217
Human Reproduction Update, 29, 2, pp. 197-217

BACKGROUND Increasing numbers of BReast CAncer (BRCA) 1 or 2 pathogenic variant (PV) carriers, who have an inherited predisposition to breast and ovarian cancer, are being identified. Among these women, data regarding the effects of contraception on

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5bb277d926fc9ff46c6a481e0523bfc6
https://pubmed.ncbi.nlm.nih.gov/36383189

Zobrazit plný text záznamu

Cancer worry among BRCA1/2 pathogenic variant carriers choosing surgery to prevent tubal/ovarian cancer

Publikováno v: Supportive Care in Cancer, 30, 4, pp. 3409-3418
Supportive Care in Cancer, 30, 3409-3418
Supportive Care in Cancer, 30(4), 3409-3418. Springer, Cham
Supportive Care in Cancer, 30(4), 3409-3418. Springer-Verlag
Supportive care in cancer, 30(4), 3409-3418. Springer Verlag
van Bommel, M H D, Steenbeek, M P, IntHout, J, Hermens, R P M G, Hoogerbrugge, N, Harmsen, M G, van Doorn, H C, Mourits, M J E, van Beurden, M, Zweemer, R P, Gaarenstroom, K N, Slangen, B F M, Brood-van Zanten, M M A, Vos, M C, Piek, J M, van Lonkhuijzen, L R C W, Apperloo, M J A, Coppus, S F P J, Prins, J B, Custers, J A E & de Hullu, J A 2022, ' Cancer worry among BRCA1/2 pathogenic variant carriers choosing surgery to prevent tubal/ovarian cancer : course over time and associated factors ', Supportive Care in Cancer, vol. 30, no. 4, pp. 3409-3418 . https://doi.org/10.1007/s00520-021-06726-4
Supportive Care in Cancer, 30(4), 3409-3418. Springer Verlag
Supportive Care in Cancer, 30, 3409-3418. SPRINGER
Supportive Care in Cancer, 30(4), 3409-3418. SPRINGER

Objective High cancer risks, as applicable to BRCA1 and BRCA2 pathogenic variant (PV) carriers, can induce significant cancer concerns. We examined the degree of cancer worry and the course of this worry among BRCA1/2-PV carriers undergoing surgery t

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::fb8e54906427e430770ef9b47ec5df55
https://hdl.handle.net/1887/3567912

Zobrazit plný text záznamu

Association of Salpingectomy With Delayed Oophorectomy Versus Salpingo-oophorectomy With Quality of Life in BRCA1/2 Pathogenic Variant Carriers:A Nonrandomized Controlled Trial

Publikováno v: Steenbeek, M P, Harmsen, M G, Hoogerbrugge, N, de Jong, M A, Maas, A H E M, Prins, J B, Bulten, J, Teerenstra, S, van Bommel, M H D, van Doorn, H C, Mourits, M J E, van Beurden, M, Zweemer, R P, Gaarenstroom, K N, Slangen, B F M, Brood-van Zanten, M M A, Vos, M C, Piek, J M J, van Lonkhuijzen, L R C W, Apperloo, M J A, Coppus, S F P J, Massuger, L F A G, IntHout, J, Hermens, R P M G & de Hullu, J A 2021, ' Association of Salpingectomy With Delayed Oophorectomy Versus Salpingo-oophorectomy With Quality of Life in BRCA1/2 Pathogenic Variant Carriers : A Nonrandomized Controlled Trial ', JAMA Oncology, vol. 7, no. 8, pp. 1203-1212 . https://doi.org/10.1001/jamaoncol.2021.1590
JAMA Oncology, 7(8), 1203-1212. American Medical Association
JAMA Oncol
JAMA oncology, 7(8), 1203-1212. AMER MEDICAL ASSOC
Jama Oncology, 7, 8, pp. 1203-1212
Jama Oncology, 7, 1203-1212
JAMA Oncology, 7(8), 1203-1212. AMER MEDICAL ASSOC
JAMA oncology, 7(8):653331861, 1203-1212. American Medical Association

Item does not contain fulltext IMPORTANCE: Most women with a BRCA1/2 pathogenic variant undergo premature menopause with potential short- and long-term morbidity due to the current method of ovarian carcinoma prevention: risk-reducing salpingo-oophor

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0dd3ab6a57c66f8094cd4c46b7ea1c46
https://research.vumc.nl/en/publications/18584e54-1f67-47ac-b63f-6a0cff8e02d3

Zobrazit plný text záznamu

Further insights into the role of tumour characteristics in survival of young women with epithelial ovarian cancer

Autor: J.C.J. Elzakkers, M.A. van der Aa, AM van Altena, J.A. de Hullu, Marline G. Harmsen

Publikováno v: Gynecologic Oncology, 155, 213-219
Gynecologic Oncology, 155, 2, pp. 213-219

Objective Optimizing the counselling of women ≤40 years with epithelial ovarian cancer (EOC) by investigating the role of young age and tumour characteristics on overall survival (OS). Methods A retrospective population-based study was done using d

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::28a12d8a02cac97742ddc29a05f419f3
https://doi.org/10.1016/j.ygyno.2019.08.018

Zobrazit plný text záznamu

Peritoneal carcinomatosis after risk-reducing surgery in BRCA1/2 mutation carriers

Autor: Marc van Beurden, Jurgen M.J. Piek, Timothy R. Rebbeck, Leon F.A.G. Massuger, Mark H. Greene, Murray Joseph Casey, Nicoline Hoogerbrugge, Marline G. Harmsen, Joanne A. de Hullu, Brigitte F. M. Slangen, Johan Bulten, Marian J.E. Mourits

Publikováno v: Cancer. 124:952-959

BACKGROUND Risk-reducing salpingo-oophorectomy (RRSO) is recommended for BRCA1/2 mutation carriers because of their increased risk of ovarian carcinoma. Despite RRSO, metachronous peritoneal carcinomatosis occasionally is diagnosed. METHODS The liter

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::762769771b3130954933e7783f0721b8
https://doi.org/10.1002/cncr.31211

Zobrazit plný text záznamu

Opportunistic salpingectomy in women undergoing hysterectomy: Results from the HYSTUB randomised controlled trial

Autor: Saskia Houterman, L.A.M. Van Lieshout, Jurgen M.J. Piek, Ingrid Vandenput, M.J.M. de Groot, Marline G. Harmsen, Sjors F.P.J. Coppus, Brenda M. Pijlman, M.C. Vos

Publikováno v: Maturitas, 107, 1-6
Maturitas, 107, pp. 1-6

Objective To evaluate whether opportunistic salpingectomy in premenopausal women undergoing hysterectomy for benign indications is both hormonally and surgically safe, compared with hysterectomy without salpingectomy. Study design In this multicentre

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0a9ca6f56b475fbc49b5bf49ed32a46c
https://doi.org/10.1016/j.maturitas.2017.09.012

Zobrazit plný text záznamu

A patient decision aid for risk-reducing surgery in premenopausal BRCA1/2 mutation carriers: Development process and pilot testing

Autor: Nicoline Hoogerbrugge, M. Caroline Vos, Rosella P.M.G. Hermens, Helena C. van Doorn, Joanne A. de Hullu, Katja N. Gaarenstroom, Marline G. Harmsen, Leon F.A.G. Massuger, Miranda P. Steenbeek

Publikováno v: Health Expectations, 21, 659-667
Health Expectations, 21, 3, pp. 659-667
Health Expectations, 21(3), 659-667
Health Expectations, 21(3), 659-667. Wiley-Blackwell Publishing Ltd
Health Expectations : An International Journal of Public Participation in Health Care and Health Policy

Background BRCA1/2 mutation carriers’ choice between risk‐reducing salpingo‐oophorectomy (RRSO) and salpingectomy with delayed oophorectomy is very complex. Aim was to develop a patient decision aid that combines evidence with patient preferenc

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8ee8f484123c2f807da15cf486dd5899
http://hdl.handle.net/2066/192167

Zobrazit plný text záznamu

Vyhledávací nástroje:

Upřesnit hledání